Who owns AVADEL PHARMACEUTICALS PLC, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
JANUS HENDERSON GROUP PLC: 1.9% · 1,823,865 shares
Two Seas Capital LP: 0.0% · 0 shares — Two Seas Capital GP LLC: 0.0% · 0 shares — Sina Toussi: 0.0% · 0 shares
5 more 5% stakes behind a free account
See every investor who has disclosed crossing 5% of AVADEL PHARMACEUTICALS PLC.
Sign up freeEvery institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of AVADEL PHARMACEUTICALS PLC they hold. Together these 208 managers report 75.96% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. | $152M | 7,041,102 | 0.00% | 7.21% | December 31, 2025 |
| VANGUARD GROUP INC | $126M | 5,864,781 | 0.00% | 6.01% | December 31, 2025 |
206 more institutional holders behind a free account
See every manager reporting AVADEL PHARMACEUTICALS PLC, how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 58 funds hold 10.77% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | $67.8M | 0.00% | 3.22% | December 31, 2025 |
| VANGUARD EXTENDED MARKET INDEX FUND | $22.7M | 0.03% | 1.08% | December 31, 2025 |
56 more funds behind a free account
See every fund holding AVADEL PHARMACEUTICALS PLC and what share of its net assets the position represents.
Sign up freeLoading...
